Corporate Profile

Webcast ImageWebcast
Teleflex Incorporated at Deutsche Bank Securities 41st Annual Health Care Conference (Replay)
05/04/16 at 11:20 a.m. ET
Teleflex Incorporated at Deutsche Bank Securities 41st Annual Health Care Conference
Wednesday, May 4, 2016 11:20 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q1 2016 Teleflex Incorporated Earnings Conference Call (Replay)
04/28/16 at 8:00 a.m. ET
Q1 2016 Teleflex Incorporated Earnings Conference Call
Thursday, April 28, 2016 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing our pipeline; leveraging and building our core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding our margins and maintaining strong cash flow all in an effort to successfully grow our reputation as a solid investment and a profitable, strong employer. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Our products are used in a wide variety of markets and are not dependent upon any one end-market or procedure.

We are focused on achieving consistent , sustainable and profitable growth by increasing our market share and improving operating efficiencies through:

  • • the development of new products and product line extensions;

  • • the investment in new technologies and broadening their applications;

  • • the expansion of the use of existing products in existing markets, as well as in new geographic markets;

  • • leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

  • • the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.
 
Recent NewsMore »
05/03/16
Teleflex to Present at the 2nd Congress of Society of Endometriosis and Uterine Disorders (SEUD)
WAYNE, Pa.--(BUSINESS WIRE)--May 3, 2016-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its innovative minimally invasive surgery (MIS) instruments at the 2nd Congress of Society of Endometriosis and Uterine Disorders (SEUD) to be held in Barcelona, Spain on May 12-14, 2016. During the event, Teleflex will present its percutaneous surgical solutions, i... 
05/02/16
Teleflex Announces Quarterly Dividend
WAYNE, Pa.--(BUSINESS WIRE)--May 2, 2016-- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2016 to shareholders of record at the close of business on May 16, 2016. The company offers a Dividend Reinvestment & Direct Stock Purchase and Sale Plan. For information about the Plan, call 1-877-842... 
05/02/16
Teleflex to Present at the 2nd Annual Congress of the European Society for Vascular Medicine (ESVM)
WAYNE, Pa.--(BUSINESS WIRE)--May 2, 2016-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its Arrow® Interventional Access Portfolio at the 2nd Annual Congress of the European Society for Vascular Medicine (ESVM) to be held in Rome, Italy on May 8 – 10, 2016. During the event, Teleflex will highlight the Arrow® GPSCath® Balloon Dilatation Catheter f... 
04/28/16
Teleflex Reports First Quarter 2016 Results
First Quarter Revenues of $424.9 million, Down 1.1% Versus Prior Year Period; Up 1.1% on Constant Currency Basis First Quarter GAAP Diluted EPS of $1.05, Up 26.5% Over the Prior Year Period First Quarter Adjusted Diluted EPS of $1.52, up 16.9% Reaffirmed 2016 Guidance Range for Constant Currency Revenue Growth of 5.0% to 6.0% Raised 2016 Guidance Range for Adjusted Diluted EPS from $7.00 to $7.15 to $7.10 to ... 
 
Upcoming EventsMore »
There are currently no events scheduled.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.


Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet